Daniel J Weiss Selected Research

Necrosis

1/2023	Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis.
1/2022	Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury.
1/2019	Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel J Weiss Research Topics

Disease

34	Lung Diseases (Lung Disease) 01/2023 - 12/2003
17	Malaria 04/2023 - 01/2015
10	Pneumonia (Pneumonitis) 01/2022 - 05/2007
10	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 12/2003
9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 09/2010
9	Inflammation (Inflammations) 01/2019 - 07/2002
8	Asthma (Bronchial Asthma) 11/2023 - 01/2013
8	COVID-19 11/2022 - 01/2020
7	Chronic Obstructive Pulmonary Disease (COPD) 02/2023 - 09/2010
7	Lung Injury 01/2022 - 10/2005
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2020 - 09/2010
5	Sepsis (Septicemia) 01/2023 - 02/2014
4	Fibrosis (Cirrhosis) 02/2024 - 01/2008
4	Acute Lung Injury 01/2023 - 10/2005
4	Neoplasms (Cancer) 10/2022 - 07/2011
4	Wounds and Injuries (Trauma) 02/2022 - 04/2013
3	Necrosis 01/2023 - 01/2019
3	Virus Diseases (Viral Diseases) 01/2022 - 12/2003
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 01/2018
3	Emphysema 01/2021 - 10/2014
3	Infections 01/2019 - 01/2015
3	Fever (Fevers) 01/2017 - 11/2015
2	Critical Illness (Critically Ill) 01/2022 - 01/2021
2	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2018
2	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2020 - 01/2017
2	Edema (Dropsy) 01/2019 - 01/2019
2	Pulmonary Emphysema 01/2017 - 09/2010
2	Pulmonary Hypertension 10/2014 - 09/2010
2	Respiratory Hypersensitivity 02/2014 - 01/2013
2	Mesothelioma 07/2011 - 03/2007
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 02/2024
1	Teratocarcinoma 02/2024
1	Osteoarthritis 01/2023
1	Stillbirth 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	Craniocerebral Trauma (Head Injury) 02/2022
1	Pulmonary Arterial Hypertension 01/2021
1	Coronavirus Infections 01/2021
1	red meat allergy 01/2021

Drug/Important Bio-Agent (IBA)

7	Therapeutic UsesIBA 01/2023 - 01/2018
7	CytokinesIBA 07/2021 - 05/2007
6	Antimalarials (Antimalarial Agents)IBA 04/2023 - 11/2015
6	InsecticidesIBA 01/2022 - 12/2015
5	AntigensIBA 02/2024 - 07/2011
5	Proteins (Proteins, Gene)FDA Link 02/2024 - 05/2012
4	CollagenIBA 02/2024 - 01/2019
4	Indicators and Reagents (Reagents)IBA 10/2020 - 01/2016
4	OvalbuminIBA 01/2017 - 07/2011
2	EndotoxinsIBA 01/2022 - 10/2005
2	VaccinesIBA 05/2021 - 12/2019
2	C-Reactive ProteinIBA 05/2021 - 01/2017
2	Chemotactic FactorsIBA 01/2021 - 01/2019
2	SolutionsIBA 01/2021 - 01/2017
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2019
2	Pancreatic Elastase (Elastase)IBA 01/2021 - 10/2014
2	artemisinin (artemisinine)IBA 10/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2013
1	Tissue ExtractsIBA 02/2024
1	indium-bleomycinIBA 02/2024
1	Tyrosine (L-Tyrosine)FDA Link 02/2024
1	hypobromous acidIBA 02/2024
1	5'- O- (9- phenylxanthen- 9- yl)- 2'- deoxynebularineIBA 02/2024
1	Laminin (Merosin)IBA 02/2024
1	Macrophage Migration-Inhibitory FactorsIBA 11/2023
1	Collagen Type III (Type III Collagen)IBA 02/2023
1	fibulinIBA 02/2023
1	artenimol (dihydroartemisinin)IBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	piperaquineIBA 01/2023
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2023
1	IronIBA 10/2022
1	AnticoagulantsIBA 02/2022
1	Warfarin (Coumadin)FDA LinkGeneric 02/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2022
1	Clopidogrel (Plavix)FDA Link 02/2022
1	LipopolysaccharidesIBA 01/2022
1	Heparitin Sulfate (Heparan Sulfate)IBA 05/2021
1	Glycoproteins (Glycoprotein)IBA 05/2021
1	remestemcel-lIBA 05/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	GelatinIBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	HydrogelsIBA 01/2021
1	AntibodiesIBA 01/2021

Therapy/Procedure

45	Therapeutics 11/2023 - 01/2005
14	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2021 - 06/2009
6	Lung Transplantation 01/2023 - 05/2007
3	Transplantation 01/2023 - 03/2014
2	Chemoprevention 01/2023 - 10/2017
2	Punctures 01/2021 - 01/2019
2	Immunomodulation 10/2020 - 02/2016
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2008 - 01/2008
1	Induced Abortion (Induced Abortions) 01/2023
1	Drug Therapy (Chemotherapy) 10/2022
1	Blood Transfusion (Blood Transfusions) 02/2022
1	Ligation 01/2021